These medicationsincluding Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro) & Retatrutide work by: Reducing appetite and cravings Slowing stomach emptying to help you feel full longer Improving blood sugar and insulin sensitivity When combined with lifestyle support, GLP-1s can help you achieve and maintain meaningful, sustainable weight loss
The differences in cardiovascular outcomes between the various GLP-1RA currently available for the treatment of patients with T2DM may be the result of differences in study design or patient populations
Below is a clinicians view of why it happens, what counts as normal, and the warning signs that mean you should stop waiting it out and speak to a doctor
Minimizing Side Effects One of the primary reasons for gradual dosing is to minimize potential side effects, particularly those affecting the gastrointestinal system
Begin with whole fruits, root vegetables and well-cooked starches such as white rice

Contact your doctor immediately if you experience: Severe, persistent abdominal pain that may indicate pancreatitis, particularly if radiating to the back or accompanied by vomiting Signs of gallbladder disease , including right upper quadrant pain, fever, jaundice, or clay-colored stools (cholelithiasis rates in clinical trials range from approximately 0.6% to 2.5%, depending on dose and duration) Symptoms of acute kidney injury , such as decreased urination, swelling, fatigue, or confusion, especially if accompanied by dehydration Visual changes , including blurred vision or difficulty focusing, which may indicate diabetic retinopathy complications (rapid glycemic improvement with tirzepatide can temporarily worsen retinopathy) Severe allergic reactions , including rash, itching, swelling of face or throat, severe dizziness, or difficulty breathing Persistent vomiting or diarrhea lasting more than 24 hours, which increases dehydration and acute kidney injury risk Symptoms suggesting thyroid tumors , including neck mass, hoarseness, dysphagia, or dyspnea New or worsening depression, suicidal thoughts, or unusual changes in mood or behavior , particularly in patients taking Zepbound for weight management Routine monitoring should include periodic assessment of renal function, particularly in patients with pre-existing kidney disease or those experiencing significant gastrointestinal symptoms
